Pick the relation: C = C₀·e−kt, LD = Vd·C/(S·F), maintenance rate = CL·Css/(S·F), τ = ln(Cpeak/Ctrough)/k.
For kidney function, estimate CrCl with Cockcroft–Gault first, then scale the dose or the interval.
Check the result: levels fall by half every half-life, and steady state takes about five half-lives.
2Practice problems
1.PharmacologyMedium
Which blood test is commonly used to monitor a continuous infusion of unfractionated heparin?
AHaemoglobin A1c
BINR (international normalised ratio, prothrombin time)
CSerum potassium
DActivated partial thromboplastin time (aPTT)
2.PharmacologyHard
Why must several weeks pass before starting an MAO inhibitor after stopping fluoxetine?
AFluoxetine must first be converted into an MAO inhibitor
BFluoxetine and its active metabolite have very long half-lives
CFluoxetine permanently and irreversibly blocks MAO enzymes
DMAO inhibitors are absorbed only after fluoxetine is gone
3.Dosage calculationsMedium
A child weighing 16 kg is prescribed 5 mg/kg of a drug. The stock solution contains 10 mg/mL. Draw up the dose: what volume V do you give?
16 kg5 mg/kg10 mg/mL
V = mL
4.Dosage calculationsHard
A patient weighs 28.6 lb. The prescription is 15 mg/kg as a single dose, and the stock contains 10 mg in 1 mL. Using 1 kg = 2.2 lb, what volume V do you give?
28.6 lb15 mg/kg10 mg/1 mL1 kg = 2.2 lb
V = mL
5.Clinical pharmacokineticsMedium
Practice exercise (made-up values, not clinical guidance). After an IV dose of vancomycin, the level is 30 mg/L at 2 h and 15 mg/L at 14 h. Assume first-order elimination. Find the half-life t½.
C1 = 30 mg/L (2 h)C2 = 15 mg/L (14 h)
t½ = h
6.Clinical pharmacokineticsHard
Practice exercise (made-up values, not clinical guidance). A 63 kg patient takes oral theophylline (F = 1) every 8 h. The clearance is 0.03 L/kg/h. What dose D in mg gives an average steady-state level of 10 mg/L?
Answer: D · Activated partial thromboplastin time (aPTT)
Why this is the answer
Unfractionated heparin is often monitored with the aPTT, and the infusion rate is adjusted according to a protocol. Low-molecular-weight heparins usually do not need routine aPTT checks.
Answer
D · Activated partial thromboplastin time (aPTT)
2.Pharmacology
Answer: B · Fluoxetine and its active metabolite have very long half-lives
Why this is the answer
Norfluoxetine, the active metabolite of fluoxetine, stays in the body for weeks. A long washout is needed before an MAOI to avoid serotonin syndrome.
Answer
B · Fluoxetine and its active metabolite have very long half-lives
3.Dosage calculations
Answer: V = 8 mL
Drawing up a dose: volume = (prescribed dose/stock strength) × stock volume. Convert to the same units first, then check that the volume fits the syringe and lands on one of its graduations.
Dose from body weight
D = 5·16 = 80 mg
Volume
V = 80/10 = 8 mL
On the syringe
On this 10 mL syringe every small line is 0.2 mL.
Answer
V = 8 mL
4.Dosage calculations
Answer: V = 19.5 mL
Dose calculation: the amount to give equals what is prescribed divided by what you have, times the quantity it comes in: amount = (desired dose/stock strength) × stock volume. Always keep the units the same (convert g to mg, mg to mcg first) and check that the answer is sensible.
Weight in kg
28.6/2.2 = 13 kg
Dose
15·13 = 195 mg
Volume
V = (195/10)·1 = 19.5 mL
Answer
V = 19.5 mL
5.Clinical pharmacokinetics
Answer: t½ = 12 h
Clearance and volume: at steady state the dosing rate equals the elimination rate, so the maintenance rate = CL × Css. A loading dose is LD = Vd × C/(S × F), with S the salt factor (fraction of active drug in the salt) and F the bioavailability (1 for IV). From two levels, k = ln(C₁/C₂)/Δt; for an IV bolus Vd = dose/C₀ and CL = k × Vd. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.
Elimination rate constant
k = ln(30/15)/12 = 0.6931/12 = 0.05776 h⁻¹
Half-life
t½ = 0.693/0.05776 = 12 h
Answer
t½ = 12 h
6.Clinical pharmacokinetics
Answer: D = 151.2 mg
Designing a regimen: with rapid IV doses the level falls from peak to trough during the interval, so τ = ln(Cpeak/Ctrough)/k and the dose that restores the peak is Vd × (Cpeak − Ctrough). The average steady-state level is Css,avg = S·F·dose/(CL·τ). An infusion rises as C = (R/CL)(1 − e−kt). For a drug cleared by the kidneys, the dose is scaled with the creatinine clearance. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.
Clearance
CL = 0.03·63 = 1.89 L/h
Dose
D = Css,avg·CL·τ/(S·F) = 10·1.89·8/(1·1) = 151.2 mg